Self-Serve Dialysis?
Outset Medical is looking to expand its Tablo label to include home use by sponsoring a 40-patient investigational device exemption (IDE) trial for the all-in-one dialysis device.
Read the full article » | Posted 05-10-2017
Related Articles
- Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
- Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026
- Meet the Dutch Neokidney: a New Suitcase Hemodialysis Machine Posted 01-16-2026
- Watch an AKF Webinar on Advancements in Home Dialysis Posted 12-17-2025

